The HCPLive HIV/AIDS page is a comprehensive resource for clinical news and insights on human immunodeficiency virus. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for HIV, and more.
September 28th 2023
Results from the systematic review and meta-analysis showed FMT restored the normal microbiome, reduced the risk of gastrointestinal infections, and did not lead to increased adverse events in patients with HIV.
December 15th 2021
September 13th 2021
Depression May Worsen Antiretroviral Treatment Adherence Among HIV-Infected Elderly
Following previous research that detected a greater risk of major depressive disorder development in HIV-infected patients, a new study examined the psychiatric condition's effect on adherence to antiretroviral therapy.
Stem Cell Transplantation May Hold Promise for HIV Infection Eradication
Two male patients with prolonged HIV infection who received hematopoietic stem cell transplants still remain virus-free several consecutive weeks after their antiretroviral treatments were discontinued this spring.
As pre-exposure prophylaxis (PrEP) remains at the forefront of HIV prevention research, clinical trial investigators provided an update on recent oral and topical PrEP efficacy studies at the second plenary session of the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013), held June 30 to July 3 in Kuala Lumpur, Malaysia.
Long-Term Raltegravir Effective in HIV Patients with Drug Resistance, Past Virological Failure
Results of a pair of phase 3 placebo-controlled clinical studies conducted by a worldwide team of researchers have deemed Merck's Isentress (raltegravir) antiretroviral treatment safe, tolerable, and effective in multidrug-resistant HIV patients who are naïve to integrase inhibitors.